Showing results (1-10 of 69) with videos related to
Sort By:
Pageof 7
Journal of Pediatric Hematology/Oncology|December 12, 2003
Childhood chronic immune thrombocytopenic purpura: unresolved issuesVictor S Blanchette, Victoria PriceSeminars in Thrombosis and Hemostasis|October 20, 2015
Definitions in hemophilia: resolved and unresolved issuesVictor S Blanchette, Alok SrivastavaSeminars in Thrombosis and Hemostasis|January 14, 2004
Childhood acute immune thrombocytopenic purpura: 20 years laterVictor S Blanchette, Manuel CarcaoSeminars in Thrombosis and Hemostasis|December 22, 2011
Childhood immune thrombocytopenia: a changing therapeutic landscapeVicky R Breakey, Victor S BlanchetteInfectious Disease Clinics of North America|September 11, 2007
The prevention and management of infections in children with asplenia or hypospleniaVictoria E Price, Victor S Blanchette, E Lee Ford-JonesArchives of Disease in Childhood|August 20, 2013
Quality of life in immune thrombocytopenia following treatmentJohn D Grainger, Nancy L Young, Victor S Blanchette, et al.British Journal of Haematology|June 13, 2002
DDAVP challenge tests in boys with mild/moderate haemophilia AShoshana Revel-Vilk, Victor S Blanchette, Cathy Sparling, et al.British Journal of Haematology|December 29, 2018
Health-related quality of life in children with chronic immune thrombocytopenia treated with eltrombopag in the PETIT studyJohn D Grainger, Victor S Blanchette, Kelly M Grotzinger, et al.Research and Practice in Thrombosis and Haemostasis|June 18, 2020
Clinical outcomes in hemophilia: Towards development of a core set of standardized outcome measures for researchSaunya Dover, Victor S Blanchette, Alok Srivastava, et al.The Journal of Pediatrics|October 18, 2005
Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trialsCarolyn E Beck, Paul C Nathan, Patricia C Parkin, et al.Pageof 7